TMCnet News
Emagine Solutions Technology Wins ACA Grant, Announces Open Application for Groundbreaking Arizona Maternal Health StudyEmagine Solutions Technology today announced that the Arizona Commerce Authority (ACA) has awarded the maternal health innovator a coveted $250,000 grant through its WearTech Applied Research Center. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260324163511/en/ 
Emagine is now seeking participants for its groundbreaking maternal health study. The research will use The Journey Pregnancy app and Preeclampsia Foundation Cuff Kits to assess the experiences of Arizona women using wearable devices to monitor their pregnancy health. To sign up just complete the eligibility form: https://emaginest.short.gy/WARMMStudy With a focus on de-risking investment in future-of-health, biomedical, and other technologies, the WearTech Applied Research Center has supported countless projects since its inception in 2019, in partnership with Arizona universities. The funds will allow Emagine and its partners at The Preeclampsia Foundation to conduct vital research into the impact of technology and wearable devices on pregnancy health. Emagine seeks applicants for groundbreaking maternal health study Emagine is now seeking participants for its maternal health technology study. Conducted alongside Dr. Sharon Thompson, OBGYN - Science and Tech Advisor for Emagine - the research will leverage The Journey Pregnancy app and Preeclampsia Foundation Cuff Kits to assess the experiences of Arizona women using wearable devices to monitor their pregnancy health. Patients must be 18 or older, live in Arizona, and currently pregnant. Participants will receive:
Research areas include:
"According to The Commonwealth Fund, our state ranks 44 out of 51 in the country for maternal outcomes, so we believe there is an opportunity to make an impact through this project," says Emagine Solutions Technology Co-founder and CEO Courtney Williams. "Hypertension in particular is a critical area to study, as women who experience a condition like preeclampsia are 3 to 4 times more likely to have heart issues later on in life. Ultimately, the more feedback and data we can gather, the better we can understand how to use technology to make pregnancy care safer, lower cost, and improve outcomes." Those interested in participating in Emagine's maternal health study just need to complete the eligibility form: https://emaginest.short.gy/WARMMStudy About Emagine Solutions Technology An award-winning healthcare technology company, Emagine is your companion for a safe pregnancy. We are tackling the U.S. maternal health crisis with AI-driven remote patient monitoring software for better outcomes. To find out more, visit emaginest.com and follow Emagine on Instagram, Twitter, TikTok and Facebook.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260324163511/en/ |
